{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:27:28Z","timestamp":1792099648373,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T00:00:00Z","timestamp":1437523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10157-015-1146-7","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T12:49:24Z","timestamp":1437482964000},"page":"284-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST)"],"prefix":"10.1007","volume":"20","author":[{"given":"Osamu","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ishige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Akiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Ishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Guili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Touya","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikatsu","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,22]]},"reference":[{"issue":"3922","key":"1146_CR1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","volume":"167","author":"JA Kint","year":"1970","unstructured":"Kint JA. Fabry\u2019s disease: alpha-galactosidase deficiency. Science. 1970;167(3922):1268\u20139.","journal-title":"Science"},{"key":"1146_CR2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ymgme.2013.02.003","volume":"109","author":"PN Francesco De","year":"2013","unstructured":"De Francesco PN, Mucci JM, Ceci R, et al. Fabry disease peripheral blood immune cells release inflammatory cytokines: role of globotriaosylceramide. Mol Genet Metab. 2013;109:93\u20139.","journal-title":"Mol Genet Metab"},{"issue":"Suppl 2","key":"1146_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1012475908718","volume":"24","author":"JP Gr\u00fcnfeld","year":"2001","unstructured":"Gr\u00fcnfeld JP, Lidove O, Joly D, Barbey F. Renal disease in Fabry patients. J Inherit Metab Dis. 2001;24(Suppl 2):71\u20134.","journal-title":"J Inherit Metab Dis"},{"key":"1146_CR4","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/ndt\/gfp031","volume":"24","author":"R Schiffmann","year":"2009","unstructured":"Schiffmann R, Warnock DG, Banikazemi M, et al. Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy. Nephrol Dial Transpl. 2009;24:2102\u201311.","journal-title":"Nephrol Dial Transpl"},{"issue":"9725","key":"1146_CR5","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(10)60653-8","volume":"375","author":"S Waldek","year":"2010","unstructured":"Waldek S, Germain DP, Wanner C, Warnock DG. Enzyme replacement therapy for Fabry\u2019s disease. Lancet. 2010;375(9725):1523.","journal-title":"Lancet"},{"key":"1146_CR6","unstructured":"Kodama C, Nakao M, Takenaka T. Is Fabry disease a rare disease? On screening of Fabry disease in chronic dialysis male patients and its clinical feature. The report of idiopathic cardiomyopathy The Ministry of Health and Welfare, 1995; 41\u20134."},{"key":"1146_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s101570050061","volume":"4","author":"K Utsumi","year":"2000","unstructured":"Utsumi K, Kase R, Takata T, et al. Fabry disease in patients receiving maintenance dialysis. Clin Exp Nephrol. 2000;4:49\u201351.","journal-title":"Clin Exp Nephrol"},{"issue":"Suppl 1","key":"1146_CR8","first-page":"113","volume":"25","author":"M Spada","year":"2002","unstructured":"Spada M, Pagliardini S. Screening for Fabry disease in end-stage nephropathies. J Inherit Metab Dis. 2002;25(Suppl 1):113.","journal-title":"J Inherit Metab Dis"},{"key":"1146_CR9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1093\/ndt\/gfg194","volume":"18","author":"GE Linthorst","year":"2003","unstructured":"Linthorst GE, Hollak CE, Korevaar JC, et al. Alpha-Galactosidase a deficiency in Dutch patients on dialysis: a critical appraisal of screening for Fabry disease. Nephrol Dial Transpl. 2003;18:1581\u20134.","journal-title":"Nephrol Dial Transpl"},{"key":"1146_CR10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao S, Kodama C, Takenaka T, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype. Kidney Int. 2003;64:801\u20137.","journal-title":"Kidney Int"},{"key":"1146_CR11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/01.ASN.0000124671.61963.1E","volume":"15","author":"P Kotanko","year":"2004","unstructured":"Kotanko P, Kramar R, Devrnja D, et al. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. J Am Soc Nephrol. 2004;15:1323\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"1146_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5414\/CNP64281","volume":"64","author":"M Tanaka","year":"2005","unstructured":"Tanaka M, Ohashi T, Kobayashi M, et al. Identification of Fabry\u2019s disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. Clin Nephrol. 2005;64:281\u20137.","journal-title":"Clin Nephrol"},{"key":"1146_CR13","doi-asserted-by":"crossref","first-page":"c33","DOI":"10.1159\/000085709","volume":"101","author":"S Bekri","year":"2005","unstructured":"Bekri S, Enica A, Ghafari T, et al. Fabry disease in patients with end-stage renal failure: the potential benefits of screening. Nephron Clin Pract. 2005;101:c33\u20138.","journal-title":"Nephron Clin Pract"},{"key":"1146_CR14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s10157-005-0369-4","volume":"9","author":"M Ichinose","year":"2005","unstructured":"Ichinose M, Nakayama M, Ohashi T, et al. Significance of screening for Fabry disease among male dialysis patients. Clin Exp Nephrol. 2005;9:228\u201332.","journal-title":"Clin Exp Nephrol"},{"key":"1146_CR15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfl528","volume":"22","author":"M Merta","year":"2007","unstructured":"Merta M, Reiterova J, Ledvinova J, et al. A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population. Nephrol Dial Transpl. 2007;22:179\u201386.","journal-title":"Nephrol Dial Transpl"},{"key":"1146_CR16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/08860220802353777","volume":"30","author":"DB Porsch","year":"2008","unstructured":"Porsch DB, Nunes AC, Milani V, et al. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report. Ren Fail. 2008;30:825\u201330.","journal-title":"Ren Fail"},{"key":"1146_CR17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1159\/000250968","volume":"30","author":"H Fujii","year":"2009","unstructured":"Fujii H, Kono K, Goto S, et al. Prevalence and cardiovascular features of Japanese hemodialysis patients with Fabry disease. Am J Nephrol. 2009;30:527\u201335.","journal-title":"Am J Nephrol"},{"key":"1146_CR18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/ndt\/gfm532","volume":"23","author":"W Terryn","year":"2008","unstructured":"Terryn W, Poppe B, Wuyts B, et al. Two-tier approach for the detection of alpha-galactosidase a deficiency in a predominantly female haemodialysis population. Nephrol Dial Transpl. 2008;23:294\u2013300.","journal-title":"Nephrol Dial Transpl"},{"key":"1146_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2350-11-19","volume":"11","author":"P Gaspar","year":"2010","unstructured":"Gaspar P, Herrera J, Rodrigues D, et al. Frequency of Fabry disease in male and female haemodialysis patients in Spain. BMC Med Genet. 2010;11:19.","journal-title":"BMC Med Genet"},{"key":"1146_CR20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3109\/0886022X.2012.669300","volume":"34","author":"T Nishino","year":"2012","unstructured":"Nishino T, Obata Y, Furusu A, et al. Identification of a novel mutation and prevalence study for Fabry disease in Japanese dialysis patients. Ren Fail. 2012;34:566\u201370.","journal-title":"Ren Fail"},{"key":"1146_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/jhg.2012.68","volume":"57","author":"K Doi","year":"2012","unstructured":"Doi K, Noiri E, Ishizu T, et al. High-throughput screening identified disease-causing mutants and functional variants of \u03b1-galactosidase A gene in Japanese male hemodialysis patients. J Hum Genet. 2012;57:575\u20139.","journal-title":"J Hum Genet"},{"key":"1146_CR22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5414\/CN107097","volume":"78","author":"Y Kikumoto","year":"2012","unstructured":"Kikumoto Y, Sugiyama H, Morinaga H, et al. The frequency of Fabry disease with the E66Q variant in the \u03b1-galactosidase A gene in Japanese dialysis patients: a case report and a literature review. Clin Nephrol. 2012;78:224\u20139.","journal-title":"Clin Nephrol"},{"key":"1146_CR23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2215\/CJN.08780812","volume":"8","author":"H Maruyama","year":"2013","unstructured":"Maruyama H, Takata T, Tsubata Y, et al. Screening of male dialysis patients for Fabry disease by plasma globotriaosylsphingosine. Clin J Am Soc Nephrol. 2013;8:629\u201336.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1146_CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1744-9987.2011.01050.x","volume":"16","author":"S Nakai","year":"2012","unstructured":"Nakai S, Iseki K, Itami N, et al. Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial. 2012;16:11\u201353.","journal-title":"Ther Apher Dial"},{"issue":"9","key":"1146_CR25","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00467-008-0846-6","volume":"23","author":"T Kitagawa","year":"2008","unstructured":"Kitagawa T, Suzuki K, Ishige N, et al. Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes. Pediatr Nepherol. 2008;23(9):1461\u201371.","journal-title":"Pediatr Nepherol"},{"key":"1146_CR26","first-page":"157","volume":"81","author":"RJ Desnick","year":"1973","unstructured":"Desnick RJ, Allen KY, Desnick SJ, et al. Fabry\u2019s disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine and leukocytes. J Lab Clin Med. 1973;81:157\u201371.","journal-title":"J Lab Clin Med"},{"key":"1146_CR27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","volume":"112","author":"JS Mayes","year":"1981","unstructured":"Mayes JS, Scheerer JB, Sifers RN, et al. Differential assay for lysosomal \u03b1-galactosidase in human tissues and its application to Fabry\u2019s disease. Clin Chim Acta. 1981;112:247\u201351.","journal-title":"Clin Chim Acta"},{"key":"1146_CR28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ymgme.2012.10.018","volume":"107","author":"M Kobayashi","year":"2012","unstructured":"Kobayashi M, Ohashi T, Fukuda T, et al. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the \u03b1-galactosidase A gene. Mol Genet Metab. 2012;107:711\u20135.","journal-title":"Mol Genet Metab"},{"key":"1146_CR29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/jhg.2010.58","volume":"55","author":"BH Lee","year":"2010","unstructured":"Lee BH, Heo SH, Kim GH, et al. Mutations of the GLA gene in Korean patients with Fabry disease and frequency of the E66Q allele as a functional variant in Korean newborns. J Hum Genet. 2010;55:512\u20137.","journal-title":"J Hum Genet"},{"key":"1146_CR30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/jhg.2013.48","volume":"58","author":"T Inoue","year":"2013","unstructured":"Inoue T, Hattori K, Ihara K, et al. Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study. J Hum Genet. 2013;58:548\u201352.","journal-title":"J Hum Genet"},{"issue":"33","key":"1146_CR31","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.2174\/13816128113199990352","volume":"19","author":"A Tuttolomondo","year":"2013","unstructured":"Tuttolomondo A, Pecoraro R, Simonetta I, et al. Anderson-Fabry disease: a multiorgan disease. Curr Pharm Des. 2013;19(33):5974\u201396.","journal-title":"Curr Pharm Des"},{"key":"1146_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM197307052890103","volume":"289","author":"RO Brady","year":"1973","unstructured":"Brady RO, Tallman JF, Johnson WG, et al. Replacement therapy for inherited enzyme deficiency. Use of purified ceramidetrihexosidase in Fabry\u2019s disease. N Engl J Med. 1973;289:9\u201314.","journal-title":"N Engl J Med"},{"key":"1146_CR33","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1073\/pnas.76.10.5326","volume":"76","author":"RJ Desnick","year":"1979","unstructured":"Desnick RJ, Dean KJ, Grabowski G, et al. Enzyme therapy in Fabry disease: differential in vivo plasma clearance and metabolic effectiveness of plasma and splenic alpha-galactosidase a isozymes. Proc Natl Acad Sci USA. 1979;76:5326\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1146_CR34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/joim.12077","volume":"274","author":"F Weidemann","year":"2013","unstructured":"Weidemann F, Niemann M, St\u00f6rk S, et al. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med. 2013;274(4):331\u201341.","journal-title":"J Intern Med"},{"key":"1146_CR35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1750-1172-6-69","volume":"6","author":"BE Smid","year":"2011","unstructured":"Smid BE, Rombach SM, Aerts JM, et al. Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients. Orphanet J Rare Dis. 2011;6:69.","journal-title":"Orphanet J Rare Dis"},{"key":"1146_CR36","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1517\/14712598.4.7.1167","volume":"4","author":"RJ Desnick","year":"2004","unstructured":"Desnick RJ. Enzyme replacement therapy for Fabry disease: lessons from two alpha-galactosidase a orphan products and one FDA approval. Expert Opin Biol Ther. 2004;4:1167\u201376.","journal-title":"Expert Opin Biol Ther"},{"issue":"Suppl 2","key":"1146_CR37","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.1016\/S0248-8663(10)70018-7","volume":"31","author":"R Demontis","year":"2010","unstructured":"Demontis R. Diagnosis of Fabry disease: usefulness of the clinical investigation. Rev Med Intern. 2010;31(Suppl 2):S229\u201332.","journal-title":"Rev Med Intern"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-015-1146-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-015-1146-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-015-1146-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:44:45Z","timestamp":1559112285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-015-1146-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,22]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1007\/s10157-015-1146-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,22]]}}}